文献速递神经核医学

血浆葡萄糖水平对轻度认知障碍患者脑FDG摄取模式及FDG PET预测效能的影响

Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-03-03

基于阿尔茨海默病神经影像学倡议(ADNI)中认知稳定≥36个月的正常对照87例和随访≥36个月的轻度认知障碍(MCI)患者323例(其中73例在36个月内进展为AD痴呆),分析血糖水平(BGL)与脑FDG摄取的相关性及其对FDG PET预测MCI向AD痴呆进展效能的影响。正常对照中BGL(59-149 mg/dl)与枕叶皮质及楔前叶(保留后扣带回)FDG摄取呈负相关,独立于淀粉样蛋白β和ApoE4状态。MCI中AD典型区域FDG摄取预测AD痴呆的ROC曲线下面积为0.804,按BGL校正后预测效能无显著变化(面积=0.808,p=0.311)。

要点

  • 正常对照中BGL 59-149 mg/dl与枕叶皮质及楔前叶FDG摄取负相关,独立于淀粉样蛋白β和ApoE4状态。
  • MCI中AD典型区域FDG摄取预测AD痴呆的ROC曲线下面积为0.804。
  • 按BGL校正后预测效能无显著变化(面积=0.808,p=0.311)。

核心结论

  • BGL升高与后部皮质FDG摄取相对减低相关,即使在≤160 mg/dl的「可接受」范围内。
  • BGL相关模式与典型AD模式相似但不完全相同。
  • BGL相关的区域FDG摄取变异对FDG PET预测MCI向AD痴呆进展的效能无相关影响。

研究设计与样本

  • 研究纳入ADNI中PET后认知稳定≥36个月的正常对照87例(74.2±5.3岁)和随访≥36个月(未提前进展为AD痴呆)的MCI患者323例(71.1±7.1岁),其中73例MCI在36个月内进展为AD痴呆。
  • 正常对照中,对parenchyma-scaled FDG摄取与BGL的相关性进行簇分析,采用family-wise误差校正5%水平。
  • MCI中,采用ROC分析评估预定义AD典型区域FDG摄取预测AD痴呆的效能;基于正常对照线性回归按BGL校正AD典型区域平均FDG摄取后重复ROC分析。

主要发现

  • 正常对照中BGL(59-149 mg/dl)与枕叶皮质及楔前叶(保留后扣带回)簇FDG摄取呈负相关,独立于淀粉样蛋白β和ApoE4状态。
  • MCI中AD典型区域FDG摄取预测AD痴呆的ROC曲线下面积为0.804。
  • 按BGL(55-189 mg/dl)校正AD典型区域FDG摄取后,预测效能无显著变化(面积=0.808,p=0.311)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Increased blood glucose level (BGL) has been reported to cause alterations of FDG uptake in the brain that mimic Alzheimer's disease (AD), even within the "acceptable" range ≤ 160 mg/dl. The aim of this study was (i) to confirm this in a large sample of well-characterized normal control (NC) subjects, and (ii) to analyze its impact on the prediction of AD dementia (ADD) in mild cognitive impairment (MCI). METHODS: The study included NCs from the Alzheimer's Disease Neuroimaging Initiative (ADNI) that were cognitively stable for ≥36 months after PET (n = 87, 74.2 ± 5.3 y), and ADNI MCIs with ≥36 months follow-up if not progressed to ADD earlier (n = 323, 71.1 ± 7.1 y). Seventy-three of the MCIs had progressed to ADD within 36 months. In the NCs, parenchyma-scaled FDG uptake was tested for clusters of correlation with BGL on the family-wise, error-corrected 5% level. In the MCIs, ROC analysis was used to assess the power of FDG uptake in a predefined AD-typical region for prediction of ADD. ROC analysis was repeated after correcting mean FDG uptake in the AD-typical region for BGL based on linear regression in the NCs. RESULTS: In the NCs, BGL (59-149 mg/dl) was negatively correlated with FDG uptake in a cluster comprising the occipital cortex and precuneus but sparing the posterior cingulate, independent of amyloid-β and ApoE4 status. In the MCIs, FDG uptake in the AD-typical region provided an area of 0.804 under the ROC curve for prediction of ADD. Correcting FDG uptake in the AD-typical region for BGL (55-189 mg/dl) did not change predictive performance (area = 0.808, p = 0.311). CONCLUSIONS: Increasing BGL is associated with relative reduction of FDG uptake in the posterior cortex even in the "acceptable" range ≤ 160 mg/dl. The BGL-associated pattern is similar to the typical AD pattern, but not identical. BGL-associated variability of regional FDG uptake has no relevant impact on the power of FDG PET for prediction of MCI-to-ADD progression.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Apostolova I, Lange C, Suppa P, et al. Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment. Eur J Nucl Med Mol Imaging. 2018. PMID: 29502311. doi:10.1007/s00259-018-3985-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。